Moneycontrol
HomeNewsBusinessMutual FundsBetting on healthcare, good quality industrials: Navneet Munot, SBI MF
Trending Topics

Betting on healthcare, good quality industrials: Navneet Munot, SBI MF

The current crisis may force marginal players to shut shop, he feels.

April 07, 2020 / 20:10 IST
Story continues below Advertisement

With equity markets falling prey to coronavirus-induced volatilty, heavy lifting has to be done on the policy front, according to SBI Mutual Fund’s Chief Investment Officer Navneet Munot.

"The policy response on both these fronts will determine how quickly economic normalcy returns," he told Moneycontrol.

Story continues below Advertisement

While these uncertainties may keep markets volatile in the near term, several valuation measures such as market cap to GDP and long-term earnings-based yield spread are in the vicinity of global financial crisis lows, suggesting attractive entry points for long-term investors, Munot said.

Sentiment measures too suggest that the pendulum has swung towards extreme pessimism which is positive for prospective returns in general. Also it is becoming increasingly clear that the unprecedented crisis will lead to unprecedented global stimulus

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show